President's Perspective
2009 Year in Review
2009 was a tremendous year here at the Sabin Vaccine Institute as we strove to fulfill our mission of reducing human suffering caused by infectious and neglected tropical diseases (NTDs).
From the launch of the first-ever World Pneumonia Day, to securing increased US funding for the control and elimination of NTDs, to the start of the GLP toxicology study for the Na-GST-1 Hookworm Vaccine, to the mobilization of scores of African and Asian leaders for sustainable immunization financing, collectively, the Institute led a large number of efforts to address the burden of hundreds of millions of the world’s poorest individuals suffering from treatable and preventable diseases.
In the News
New England Journal of Medicine Studies Affirm World Health Organization Recommendation to Include Rotavirus Vaccines in Every Nation’s Immunization Program
For the first time ever, studies published last month by the New England Journal of Medicine have confirmed a direct link between rotavirus vaccine and a reduction of diarrheal disease deaths based on data from three year-long studies conducted in Malawi, Mexico, and South Africa.
Rotavirus is the leading cause of severe diarrhea, which claims the lives of more than 500,000 children under age 5 every year – with almost half of these deaths occurring in Africa – and causes the hospitalization of millions more.
Findings in Mexico showed that diarrheal disease death rates dropped by more than 65 percent among children age two and under during the 2009 rotavirus season after the introduction of the Rotarix™ vaccine developed by GlaxoSmithKline Biologicals (GSK).
We’re scientists. We’re researchers. And we’re advocates for a world free of needless suffering.
We develop new vaccines to combat neglected and global health threats, while simultaneously ensuring that existing and effective treatments get into the hands of people in need. We are particularly committed to saving lives in the world’s areas of greatest neglect, poverty, and destitution. We build bridges between leaders in science, academia, industry and government to conduct critical research to catalyze these solutions.
We’re a non-profit 501c3 with generous support from the Bill & Melinda Gates Foundation and other organizations and individuals dedicated to our mission of reducing human suffering from neglected and devastating diseases. Everyday, our work is lifting people out of poverty, improving and saving lives.
Latest Sabin News
02.01.10 : WHO Pneumonia Expert Recognized for Efforts to Ensure Children Receive Life-saving Vaccines
[read more]
02.01.10 : The Global Network for Neglected Tropical Diseases Applauds Obama Administration’s Commitment to Controlling and Eliminating NTDs
[read more]
01.29.10 : PACE Applauds Gates Foundation's $10B Vaccine Commitment
[read more]